Interleukin-17 and type 17 helper T cells.
Miossec
Pierre
P
Department of Immunology and Rheumatology, Hôpital Edouard Herriot, University of Lyon, Lyon, France. miossec@univ-lyon1.fr
Korn
Thomas
T
Kuchroo
Vijay K
VK
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D002454:Cell Differentiation / Q000276:immunology; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D020381:Interleukin-17 / Q000276:immunology*; D051379:Mice; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors; D053722:Receptors, Interleukin-17 / Q000037:antagonists & inhibitors; D019947:Receptors, Interleukin-6 / Q000037:antagonists & inhibitors / Q000276:immunology; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology*
D000911:Antibodies, Monoclonal; D020381:Interleukin-17; D017472:Receptors, Interleukin-1; D053722:Receptors, Interleukin-17; D019947:Receptors, Interleukin-6